Allergy Diagnostics Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Allergy Diagnostics Market

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, Luminometer), Services), Test Type (In Vivo (Skin Prick, Patch), In Vitro), Allergen (Food, Inhaled, Drug), End User, & Region - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 2955 Apr, 2024, by marketsandmarkets.com

The global allergy diagnostics market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the increasing initiatives for allergy research and treatment, changing environment conditions, and growing healthcare expenditure. However, false positive test results and limited access to testing services could restrain the growth of this market.

Attractive Opportunities in the Allergy Diagnostics Market

Allergy Diagnostics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Allergy Diagnostics Market

Global Allergy Diagnostics Dynamics

DRIVER: High incidence and heavy economic burden of allergic diseases

The important step in the treatment of patients suffering from allergic diseases is the allergy diagnosis. Asthma, rhinitis, angioedema, urticaria, conjunctivitis, and eczema are considered as the major allergic diseases. Additionally, across the globe, conditions such as food allergies and drug & insect allergies also affect many people. Allergies and related diseases have continued to be prevalent for more than 50 years in the industrialized world, globally. According to data from CDC’s (June 2023) National Center for Health Statistics. 27.2% of children show allergy symptoms, and 31.8% of adults, which tallies over 100 million people. The allergy cases witnessed to be high among children; sensitization rates to one or more common allergens among school children are currently approaching 40%-50%

RESTRAINT: High pricing of allergy diagnostic instruments

Key market players periodically update several Allergy Diagnostics instruments, such as luminometers, blot analyzers, scanners, ELISA analyzers, and immunoassay analyzers. These are priced at a premium (the price of each instrument varies based on its accuracy, flexibility, and TAT), as these instruments are equipped with advanced features and functionalities. For instance, Phadia 2500+ by Thermo Fisher Scientific, Inc. (US) costs USD 1,185,895, IMMULITE 2000 xpi by Siemens costs USD 20,953.8, while luminometers cost USD 3,000 and USD 14,000. Semi-automated ELISA readers cost USD 2,000 and USD 5,000, while fully automated analyzers cost around USD 14,000. Furthermore, an additional expense required to operate this equipment for maintenance and insurance, laboratory supervision, and overheads (including utilities, space, and administration).

OPPORTUNITY: Integration of AI in allergy diagnosis

In the area of data science, artificial intelligence (AI) refers to sophisticated computational devices that can interact with humans and learn from data. Early diagnosis, self-care, wellness and prevention, clinical decision support, care delivery, and chronic care management are just a few of the healthcare domains where AI may be useful. The most recent advancements in AI methodology have opened up new avenues for defining the patient-to-patient heterogeneity of allergic disorders, as discovered in paediatric allergy research.

CHALLENGE: Shortage of allergists

General practitioners could not manage the diagnosis and treatment of allergic disorders such as asthma, rhinitis, food allergies, urticaria and others is multi-faceted and complicated and thus requires the prowess of a dedicated allergy specialist. For maintaining good health for people of all ages, allergists play a vital role. However, there is now a growing shortage of allergists. For instance, the leading membership organization American Academy of Allergy, Asthma & Immunology (AAAAI), includes more than 7,000 allergists / immunologists and it is the trusted resource of patients for allergies, asthma and immune deficiency disorders. Furthermore, one San Francisco study reported that there are long scheduling waits in most areas to see allergists and the mean wait times to consult an allergist of more than 60 days (Source: Barton Associates).

ALLERGY DIAGNOSTICS ECOSYSTEM

Prominent companies in this market include well-established, financially stable manufacturers of Allergy Diagnostics. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks. Prominent companies in this market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)].

Allergy Diagnostics Market Ecosystem

“In 2023, consumables segment to observe the highest growth rate of the Allergy Diagnostics industry, by product & service.”

Based on product & service, the Allergy Diagnostics market is segmented into consumables, instruments, and services. In 2023, the consumables segment has accounted for the largest share of the Allergy Diagnostics market. Rise in number of allergy cases including respiratory and food allergies mainly and the growing need for diagnosis due to awareness about allergic symptoms to drive the market of this segment during the forecast period. Consumables segment is also expected to witness significant growth during the forecast period.

“In 2023, inhaled allergen segment to dominate the Allergy Diagnostics industry, by allergen.”

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergen, food allergen, drug allergen, and other allergens. The inhaled allergen segment dominated the Allergy Diagnostics market in 2023. This segment is also estimated to account for the highest CAGR during the forecast period. The large share of this segment can be primarily attributed to the growing air pollution and increased urbanization & indoor air quality concerns resulting in exposure to indoor air pollutants such as dust mites and spores.

“In 2023, Hospital-based laboratories & clinics segment to dominate the Allergy Diagnostics industry, by end user.”

Based on the end user, the Allergy Diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories & clinics, academic research institutes, and other end users. In 2023, the hospital-based laboratories & clinics segment accounted for the largest share of the market. The large share of the segment can be primarily attributed to the collaboration with specialists, comprehensive diagnostic services, and cost efficiency.

“In 2023, North America to dominate in Allergy Diagnostics industry.”

The global Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate during the forecast period, primarily due to the growing availability of government funding for allergy research activities, the presence of major players in the US, presence of telemedicine & remote testing, and increased collaborations and partnerships between government and allergy associations.

Allergy Diagnostics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Allergy Diagnostics market is dominated by players such as Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], Eurofins Scientific (Luxembourg), EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (Germany), bioMérieux SA (France), Stallergenes Greer Ltd. (UK), HollisterStier Allergy (US), and Omega Diagnostics Group PLC (UK).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample
Click on image to enlarge

Scope of the Report

Report Metric

Details

Market Size Available for Years

2022–2029

Base Year Considered

2023

Forecast Period

2024–2029

Forecast Units

Value (USD)

Segments Covered

Product & Service, Test Type, Allergen, and End User

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Companies Covered

Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Minaris Medical America, Inc. (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), Eurofins Scientific (Luxembourg) , Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Erba Group (UK), ALCIT INDIA PVT. LTD. (India), Biopanda Reagents (UK), Bioside S.r.l. (Italy), Creative Diagnostic Medicare Pvt. Ltd. (India), DST Diagnostische Systeme & Technologien GmbH (Germany), and Dr. Fooke Laboratorien GmbH (Germany).

This research report categorizes the Allergy Diagnostics market into the following segments:

Regional Split
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Type Split
  • Consumables
  • Instruments
  • Services
Test Type Split
  • In Vivo Tests
  • In Vitro Tests
Allergen Split
  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens
End-user Split
  • Hospitals-Based Laboratories & Clinics
  • Diagnostic Laboratories
  • Academic Research Institutes

Recent Developments of Allergy Diagnostics Industry:

  • In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, "Minaris Medical"). After this share acquisition is finished, Minaris Medical—which runs companies that deal with automated analytical tools and in vitro diagnostic reagents—will be consolidated under Canon Medical.
  • In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.
  • In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 43)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 INCLUSIONS AND EXCLUSIONS 
    1.4 MARKET SEGMENTATION 
           1.4.1 MARKETS COVERED
           1.4.2 REGIONS COVERED
           1.4.3 YEARS CONSIDERED
           1.4.4 CURRENCY CONSIDERED
    1.5 MARKET STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 48)
    2.1 RESEARCH DATA 
          FIGURE 1 ALLERGY DIAGNOSTICS MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    TABLE 1 KEY DATA FROM PRIMARY SOURCES
                    FIGURE 2 KEY INDUSTRY INSIGHTS
                    2.1.2.1 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
           2.1.3 MARKET SIZE ESTIMATION
                    FIGURE 6 BOTTOM-UP APPROACH: REVENUE-BASED APPROACH
                    2.1.3.1 Growth forecast
                    2.1.3.2 CAGR projections
                                FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.1.4 TOP-DOWN APPROACH
                    FIGURE 8 ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
    2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.3 STUDY ASSUMPTIONS 
          TABLE 2 ALLERGY DIAGNOSTICS MARKET: IMPACT ANALYSIS
    2.4 RISK ASSESSMENT 
          TABLE 3 ALLERGY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
    2.5 RESEARCH LIMITATIONS 
    2.6 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 60)
    FIGURE 10 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
    FIGURE 11 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD BILLION)
    FIGURE 12 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2024 VS. 2029 (USD BILLION)
    FIGURE 13 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
    FIGURE 14 REGIONAL SNAPSHOT OF ALLERGY DIAGNOSTICS MARKET
 
4 PREMIUM INSIGHTS (Page No. - 64)
    4.1 ALLERGY DIAGNOSTICS MARKET OVERVIEW 
          FIGURE 15 INCREASING NUMBER OF GOVERNMENT INITIATIVES AND INVESTMENTS TO DRIVE MARKET
    4.2 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN AND COUNTRY (2023) 
          FIGURE 16 CHINA AND INHALED ALLERGENS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.3 ALLERGY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
    4.4 ALLERGY DIAGNOSTICS MARKET: REGIONAL MIX 
          FIGURE 18 ASIA PACIFIC TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
    4.5 ALLERGY DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 68)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 High incidence and heavy economic burden of allergic diseases
                    5.2.1.2 Increasing awareness about allergies
                    5.2.1.3 Rising environmental pollution levels
                    5.2.1.4 Increased funding for allergy diagnostics
                    5.2.1.5 Coverage of allergy diagnosis under health insurance schemes
           5.2.2 RESTRAINTS
                    5.2.2.1 Premium cost of allergy diagnostic instruments
                    5.2.2.2 Lack of adequate knowledge and poor implementation of allergy testing methods
                    5.2.2.3 Limited access to healthcare services
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Use of mHealth in allergy diagnosis
                    5.2.3.2 Integration of artificial intelligence in allergy diagnosis
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of allergists and lack of training programs
                    5.2.4.2 Diagnostic challenges in allergic patients
           5.2.5 TRENDS
                    5.2.5.1 Rising use of reagent rental agreements and cost-per-test contracts
                    5.2.5.2 Increasing use of molecular diagnostics and point-of-care allergy testing
    5.3 PRICING ANALYSIS 
          TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
          TABLE 5 AVERAGE SELLING PRICE TREND, BY REGION
    5.4 PATENT ANALYSIS 
          FIGURE 21 PATENT ANALYSIS FOR ALLERGY DIAGNOSTIC PRODUCTS (JANUARY 2014–DECEMBER 2023)
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 ALLERGY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 24 ALLERGY DIAGNOSTICS MARKET: ECOSYSTEM/MARKET MAP
           5.7.1 ALLERGY DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
          FIGURE 25 KEY PLAYERS IN ALLERGY DIAGNOSTICS MARKET
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 6 ALLERGY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 DEGREE OF COMPETITION
           5.8.2 BARGAINING POWER OF SUPPLIERS
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 THREAT OF SUBSTITUTES
           5.8.5 THREAT OF NEW ENTRANTS
    5.9 REGULATORY ANALYSIS 
           5.9.1 REGULATORY LANDSCAPE
                    5.9.1.1 North America
                               5.9.1.1.1 US
                                              TABLE 7 US: CLASSIFICATION OF IMMUNOASSAY PRODUCTS
                                              FIGURE 26 US: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
                               5.9.1.1.2 Canada
                                              FIGURE 27 CANADA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
                    5.9.1.2 Europe
                                TABLE 8 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
                                FIGURE 28 EUROPE: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
                               5.9.1.2.1 Russia
                                              TABLE 9 RUSSIA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
                    5.9.1.3 Asia Pacific
                               5.9.1.3.1 Japan
                                              FIGURE 29 JAPAN: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
                                              TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.9.1.3.2 China
                                              TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.9.1.3.3 India
                                              FIGURE 30 INDIA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
                               5.9.1.3.4 Indonesia
                                              TABLE 12 INDONESIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.9.1.3.5 South Korea
                                              TABLE 13 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.9.1.4 Middle East & Africa
                               5.9.1.4.1 Saudi Arabia
                                              TABLE 14 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.9.1.5 Latin America
                               5.9.1.5.1 Mexico
                                              FIGURE 31 MEXICO: REGULATORY PROCESS FOR IN-VIRTO DIAGNOSTIC DEVICES
                                              TABLE 15 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.9.1.5.2 Brazil
                                              FIGURE 32 BRAZIL: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
           5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 18 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 TRADE ANALYSIS 
           5.10.1 EXPORT DATA FOR HS CODE 902750
                     TABLE 20 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019–2023 (USD MILLION)
           5.10.2 IMPORT DATA FOR HS CODE 902750
                     TABLE 21 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019–2023 (USD MILLION)
    5.11 TECHNOLOGY ANALYSIS 
           5.11.1 ALLERGY DIAGNOSTICS MARKET: KEY TECHNOLOGIES
                     TABLE 22 KEY TECHNOLOGIES IN ALLERGY DIAGNOSTICS MARKET
           5.11.2 ALLERGY DIAGNOSTICS MARKET: COMPLEMENTARY TECHNOLOGIES
    5.12 KEY CONFERENCES AND EVENTS, 2024−2025 
           TABLE 23 ALLERGY DIAGNOSTICS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
           FIGURE 33 REVENUE SHIFT IN ALLERGY DIAGNOSTICS
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
                     TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
           5.14.2 KEY BUYING CRITERIA
                     FIGURE 35 KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS
                     TABLE 25 KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS
 
6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE (Page No. - 102)
    6.1 INTRODUCTION 
          TABLE 26 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
    6.2 CONSUMABLES 
           6.2.1 RECURRENT USE TO DRIVE MARKET
                    TABLE 27 ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 28 NORTH AMERICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 29 EUROPE: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 30 ASIA PACIFIC: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 31 LATIN AMERICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 32 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 INSTRUMENTS 
          TABLE 33 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 34 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 35 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 36 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 37 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 38 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 39 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 IMMUNOASSAY ANALYZERS
                    6.3.1.1 High preference for testing to boost demand
                                TABLE 40 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 41 NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 42 EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 44 LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 45 MIDDLE EAST & AFRICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 LUMINOMETERS
                    6.3.2.1 Convenience and ease of use to drive market
                                TABLE 46 LUMINOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 47 NORTH AMERICA: LUMINOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 48 EUROPE: LUMINOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 49 ASIA PACIFIC: LUMINOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 50 LATIN AMERICA: LUMINOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 51 MIDDLE EAST & AFRICA: LUMINOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 OTHER INSTRUMENTS
                    TABLE 52 ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 53 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 54 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 55 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 56 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 57 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
    6.4 SERVICES 
           6.4.1 RISING NEED TO ENSURE EFFECTIVE UTILIZATION OF ALLERGY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
                    TABLE 58 ALLERGY DIAGNOSTIC SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 59 NORTH AMERICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 60 EUROPE: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 61 ASIA PACIFIC: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 62 LATIN AMERICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 63 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE (Page No. - 121)
    7.1 INTRODUCTION 
          TABLE 64 ADVANTAGES AND LIMITATIONS OF ALLERGY TESTS
          TABLE 65 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
    7.2 IN VIVO TESTS 
          TABLE 66 ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 67 ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 68 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 69 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 70 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 71 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 72 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.1 SKIN PRICK TESTS
                    7.2.1.1 Most widely preferred in vivo allergy tests
                                TABLE 73 SKIN PRICK TESTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 74 NORTH AMERICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 75 EUROPE: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 76 ASIA PACIFIC: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 77 LATIN AMERICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 78 MIDDLE EAST & AFRICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.2 PATCH TESTS
                    7.2.2.1 Rapid diagnosis of contact dermatitis to boost demand
                                TABLE 79 PATCH TESTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 80 NORTH AMERICA: PATCH TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 81 EUROPE: PATCH TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 82 ASIA PACIFIC: PATCH TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 83 LATIN AMERICA: PATCH TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 84 MIDDLE EAST & AFRICA: PATCH TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           7.2.3 OTHER IN VIVO TESTS
                    TABLE 85 OTHER IN VIVO TESTS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 86 NORTH AMERICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 87 EUROPE: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 89 LATIN AMERICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 90 MIDDLE EAST & AFRICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 IN VITRO TESTS 
           7.3.1 ABILITY TO IDENTIFY ALLERGEN-SPECIFIC IGE MOLECULES IN A PATIENT’S SERUM TO DRIVE MARKET
                    TABLE 91 ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 92 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 93 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 94 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 95 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 96 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN (Page No. - 137)
    8.1 INTRODUCTION 
          TABLE 97 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
    8.2 INHALED ALLERGENS 
           8.2.1 HIGH INCIDENCE OF ASTHMA TO PROPEL MARKET
                    TABLE 98 INHALED ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 99 NORTH AMERICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 100 EUROPE: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 101 ASIA PACIFIC: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 102 LATIN AMERICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 103 MIDDLE EAST & AFRICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 FOOD ALLERGENS 
           8.3.1 HIGH PREVALENCE AMONG CHILDREN TO SUPPORT MARKET GROWTH
                    TABLE 104 SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS
                    TABLE 105 FOOD ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 106 NORTH AMERICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 107 EUROPE: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 108 ASIA PACIFIC: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 109 LATIN AMERICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 110 MIDDLE EAST & AFRICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.4 DRUG ALLERGENS 
           8.4.1 INCREASING INCIDENCE OF DRUG ALLERGIES TO DRIVE MARKET
                    TABLE 111 DRUG ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 112 NORTH AMERICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 113 EUROPE: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 114 ASIA PACIFIC: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 115 LATIN AMERICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 116 MIDDLE EAST & AFRICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.5 OTHER ALLERGENS 
          TABLE 117 OTHER ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
          TABLE 118 NORTH AMERICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 119 EUROPE: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 120 ASIA PACIFIC: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 121 LATIN AMERICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 122 MIDDLE EAST & AFRICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 ALLERGY DIAGNOSTICS MARKET, BY END USER (Page No. - 151)
    9.1 INTRODUCTION 
          TABLE 123 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
    9.2 HOSPITAL-BASED LABORATORIES & CLINICS 
           9.2.1 MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS
                    TABLE 124 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 125 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 126 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 127 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 128 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 129 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 DIAGNOSTIC LABORATORIES 
           9.3.1 MAJOR END USERS OF ALLERGY DIAGNOSTIC PRODUCTS
                    TABLE 130 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 131 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 132 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 133 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 134 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 135 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 ACADEMIC RESEARCH INSTITUTES 
           9.4.1 RISING NUMBER OF INSTITUTES OFFERING ALLERGY TESTING TRAINING TO SUPPORT MARKET GROWTH
                    TABLE 136 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 137 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 138 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 139 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 140 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 141 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
    9.5 OTHER END USERS 
          TABLE 142 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 143 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 144 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 145 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 146 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 147 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
10 ALLERGY DIAGNOSTICS MARKET, BY REGION (Page No. - 165)
     10.1 INTRODUCTION 
             TABLE 148 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 36 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
                        TABLE 149 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 150 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 151 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 152 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 153 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 154 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 155 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.2.2 US
                        10.2.2.1 US to dominate North American allergy diagnostics market
                                     TABLE 156 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 157 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 158 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 159 US: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 160 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 161 US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
                                     TABLE 162 US: ALLERGY DIAGNOSTICS MARKET, BY NUMBER OF PATIENTS BEING TESTED. 2018–2029 (MILLION)
             10.2.3 CANADA
                        10.2.3.1 Rising funding activities in allergy diagnostics to drive market
                                     TABLE 163 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 164 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 165 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 166 CANADA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 167 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 168 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                        TABLE 169 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 170 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 171 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 172 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 173 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 174 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 175 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Germany to hold largest market share in Europe
                                     TABLE 176 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 177 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 178 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 179 GERMANY: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 180 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 181 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Increasing prevalence of food anaphylaxis to support market growth
                                     TABLE 182 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 183 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 184 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 185 UK: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 186 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 187 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Increasing reimbursements for allergy testing to support market growth
                                     TABLE 188 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 189 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 190 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 191 FRANCE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 192 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 193 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Presence of allergy diagnostic organizations to support research & demand for products
                                     TABLE 194 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 195 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 196 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 197 ITALY: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 198 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 199 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Government initiatives and healthcare infrastructural development to drive market
                                     TABLE 200 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 201 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 202 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 203 SPAIN: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 204 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 205 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 206 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 207 REST OF EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 208 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 209 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 210 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 211 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        FIGURE 37 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
                        TABLE 212 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 213 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 214 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 215 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 216 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 217 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 218 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 China to hold largest market share in APAC
                                     TABLE 219 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 220 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 221 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 222 CHINA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 223 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 224 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Increasing prevalence of allergies among children to propel demand for allergy diagnostics
                                     TABLE 225 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 226 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 227 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 228 JAPAN: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 229 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 230 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Limited awareness regarding allergy management to limit market growth
                                     TABLE 231 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 232 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 233 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 234 INDIA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 235 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 236 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.5 AUSTRALIA
                        10.4.5.1 High prevalence of food allergies to drive market
                                     TABLE 237 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 238 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 239 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 240 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 241 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 242 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 243 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 244 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 245 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 246 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 247 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 248 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 LATIN AMERICA: RECESSION IMPACT
                        TABLE 249 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 250 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 251 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 252 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 253 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 254 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 255 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.2 BRAZIL
                        10.5.2.1 Brazil to hold largest market share in Latin America
                                     TABLE 256 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 257 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 258 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 259 BRAZIL: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 260 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 261 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.3 MEXICO
                        10.5.3.1 Growing focus on awareness training programs to boost demand
                                     TABLE 262 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 263 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 264 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 265 MEXICO: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 266 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 267 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                        TABLE 268 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 269 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 270 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 271 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 272 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 273 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
                        TABLE 274 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
                        TABLE 275 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 276 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 277 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 278 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 279 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 280 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.6.2 GCC COUNTRIES
                        10.6.2.1 Rising healthcare spending to drive market
                                     TABLE 281 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                                     TABLE 282 GCC COUNTRIES: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 283 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                                     TABLE 284 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                                     TABLE 285 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                                     TABLE 286 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.6.3 REST OF MIDDLE EAST & AFRICA
                        TABLE 287 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
                        TABLE 288 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 289 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022–2029 (USD MILLION)
                        TABLE 290 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 291 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022–2029 (USD MILLION)
                        TABLE 292 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 233)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 293 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ALLERGY DIAGNOSTICS COMPANIES
     11.3 REVENUE ANALYSIS 
             FIGURE 38 REVENUE ANALYSIS FOR KEY COMPANIES IN ALLERGY DIAGNOSTICS MARKET, 2019–2023 (USD MILLION)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 39 ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
             TABLE 294 ALLERGY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
     11.5 BRAND/PRODUCT COMPARISON 
             FIGURE 40 ALLERGY DIAGNOSTICS MARKET: BRAND COMPARISON FOR IMMUNOASSAY ANALYZERS, BY KEY PLAYER
     11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 41 ALLERGY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             11.6.5 COMPANY FOOTPRINT ANALYSIS
                        FIGURE 42 ALLERGY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
                        TABLE 295 ALLERGY DIAGNOSTICS MARKET: PRODUCT & SERVICE FOOTPRINT
                        TABLE 296 ALLERGY DIAGNOSTICS MARKET: REGIONAL FOOTPRINT
                        TABLE 297 ALLERGY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT
                        TABLE 298 ALLERGY DIAGNOSTICS MARKET: ALLERGENS FOOTPRINT
     11.7 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2023 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 RESPONSIVE COMPANIES
             11.7.3 DYNAMIC COMPANIES
             11.7.4 STARTING BLOCKS
                        FIGURE 43 ALLERGY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
             11.7.5 COMPETITIVE BENCHMARKING
                        TABLE 299 ALLERGY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                        TABLE 300 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
                        TABLE 301 REGIONAL FOOTPRINT (STARTUPS/SMES)
                        TABLE 302 COMPANY FOOTPRINT (STARTUPS/SMES)
     11.8 VALUATION AND FINANCIAL METRICS OF ALLERGY DIAGNOSTICS VENDORS 
             FIGURE 44 EV/EBITDA OF KEY VENDORS
             FIGURE 45 EV/REV OF KEY VENDORS
             FIGURE 46 BETA (5 YEARS) OF KEY VENDORS
             FIGURE 47 1 YEAR PRICE TOTAL RETURN OF KEY VENDORS
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 303 ALLERGY DIAGNOSTICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–MARCH 2024
             11.9.2 DEALS
                        TABLE 304 ALLERGY DIAGNOSTICS MARKET: DEALS, JANUARY 2020–MARCH 2024
             11.9.3 EXPANSIONS
                        TABLE 305 ALLERGY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2020–MARCH 2024
 
12 COMPANY PROFILES (Page No. - 252)
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     12.1 KEY PLAYERS 
             12.1.1 DANAHER CORPORATION
                        TABLE 306 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 307 DANAHER CORPORATION: PRODUCTS OFFERED
             12.1.2 THERMO FISHER SCIENTIFIC INC.
                        TABLE 308 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
                        TABLE 309 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
                        TABLE 310 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
                        TABLE 311 THERMO FISHER SCIENTIFIC INC.: DEALS
             12.1.3 CANON, INC. (MINARIS MEDICAL AMERICA, INC.)
                        TABLE 312 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY OVERVIEW
                        FIGURE 50 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY SNAPSHOT (2023)
                        TABLE 313 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): PRODUCTS OFFERED
                        TABLE 314 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): DEALS
             12.1.4 SIEMENS HEALTHINEERS AG
                        TABLE 315 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
                        FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
                        TABLE 316 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
             12.1.5 EUROFINS SCIENTIFIC
                        TABLE 317 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
                        FIGURE 52 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
                        TABLE 318 EUROFINS SCIENTIFIC: PRODUCTS OFFERED
                        TABLE 319 EUROFINS SCIENTIFIC: EXPANSIONS
             12.1.6 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG)
                        TABLE 320 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY OVERVIEW
                        FIGURE 53 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY SNAPSHOT (2023)
                        TABLE 321 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): PRODUCTS OFFERED
                        TABLE 322 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): DEALS
             12.1.7 BIOMÉRIEUX SA
                        TABLE 323 BIOMÉRIEUX SA: COMPANY OVERVIEW
                        FIGURE 54 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022)
                        TABLE 324 BIOMÉRIEUX SA: PRODUCTS OFFERED
             12.1.8 STALLERGENES GREER LTD.
                        TABLE 325 STALLERGENES GREER LTD.: COMPANY OVERVIEW
                        TABLE 326 STALLERGENES GREER LTD.: PRODUCTS OFFERED
                        TABLE 327 STALLERGENES GREER LTD.: DEALS
             12.1.9 ROMER LABS DIVISION HOLDING GMBH
                        TABLE 328 ROMER LABS DIVISION HOLDING GMBH: COMPANY OVERVIEW
                        FIGURE 55 ROMER LABS DIVISION HOLDING GMBH: COMPANY SNAPSHOT (2022)
                        TABLE 329 ROMER LABS DIVISION HOLDING GMBH: PRODUCTS OFFERED
                        TABLE 330 ROMER LABS DIVISION HOLDING GMBH: DEALS
             12.1.10 HOLLISTERSTIER ALLERGY
                        TABLE 331 HOLLISTERSTIER ALLERGY: COMPANY OVERVIEW
                        FIGURE 56 JUBILANT PHARMA LIMITED: COMPANY SNAPSHOT (2022)
                        TABLE 332 HOLLISTERSTIER ALLERGY: PRODUCTS OFFERED
             12.1.11 OMEGA DIAGNOSTICS GROUP PLC
                        TABLE 333 OMEGA DIAGNOSTICS GROUP PLC: COMPANY OVERVIEW
                        FIGURE 57 OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2023)
                        TABLE 334 OMEGA DIAGNOSTICS GROUP PLC: PRODUCTS OFFERED
     12.2 OTHER PLAYERS 
             12.2.1 HOB BIOTECH GROUP CORP., LTD.
                        TABLE 335 HOB BIOTECH GROUP CORP., LTD.: COMPANY OVERVIEW
             12.2.2 HYCOR BIOMEDICAL
                        TABLE 336 HYCOR BIOMEDICAL: COMPANY OVERVIEW
             12.2.3 LINCOLN DIAGNOSTICS, INC.
                        TABLE 337 LINCOLN DIAGNOSTICS, INC.: COMPANY OVERVIEW
             12.2.4 R-BIOPHARM AG
                        TABLE 338 R-BIOPHARM AG: COMPANY OVERVIEW
             12.2.5 ASTRA BIOTECH GMBH
                        TABLE 339 ASTRA BIOTECH GMBH: COMPANY OVERVIEW
             12.2.6 ERBA GROUP
                        TABLE 340 ERBA GROUP: COMPANY OVERVIEW
             12.2.7 AESKU.GROUP GMBH
                        TABLE 341 AESKU.GROUP GMBH: COMPANY OVERVIEW
             12.2.8 ACON LABORATORIES, INC.
                        TABLE 342 ACON LABORATORIES, INC.: COMPANY OVERVIEW
             12.2.9 ALCIT INDIA PVT. LTD.
                        TABLE 343 ALCIT INDIA PVT. LTD.: COMPANY OVERVIEW
             12.2.10 BIOPANDA REAGENTS LTD.
                        TABLE 344 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
             12.2.11 BIOSIDE S.R.L.
                        TABLE 345 BIOSIDE S.R.L.: COMPANY OVERVIEW
             12.2.12 CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.
                        TABLE 346 CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.: COMPANY OVERVIEW
             12.2.13 DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH
                        TABLE 347 DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH: COMPANY OVERVIEW
             12.2.14 DR. FOOKE LABORATORIEN GMBH
                        TABLE 348 DR. FOOKE LABORATORIEN GMBH: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 299)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Allergy Diagnostics market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Allergy Diagnostics market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the Allergy Diagnostics market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as hospital-based laboratories & clinics, diagnostic laboratories, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Allergy Diagnostics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various Allergy Diagnostics were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Allergy Diagnostics market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of Allergy Diagnostics market at the regional and country-level 
  • Relative adoption pattern of each Allergy Diagnostics market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Global Allergy Diagnostics Market Size: Top Down Approach

Allergy Diagnostics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Allergy Diagnostics Market Size: Bottom-Up Approach

Allergy Diagnostics Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Allergy Diagnostics industry.

Market Definition

The purpose of allergy testing is to help identify the substances that are causing a patient's symptoms. There are several types of tests available, including as patch, blood, challenge, intradermal, and skin tests. Challenge tests, such as food, inhalation, medication, and physical challenges, are frequently performed by allergists. Blood tests are generally used when unsafe or unapplicable skin tests, such as consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests such as in vitro & in vivo tests are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • Doctors/Allergists
  • Researchers
  • Technicians
  • End Users/Operators

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the Allergy Diagnostics market by product & service, test type, allergen, end user, and region.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Allergy Diagnostics market
  • To forecast the size of the Allergy Diagnostics market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa.
  • To profile key players in the Allergy Diagnostics market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Allergy Diagnostics market.
  • To benchmark players within the Allergy Diagnostics market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Allergy Diagnostics market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Allergy Diagnostics Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 2955
Published ON
Apr, 2024
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Allergy Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback